We are deeply committed to unraveling the intricate nature of neurological disorders and pioneering innovative strategies for their treatment and prevention, with an overarching goal to facilitate the translation of research advancements into impactful patient care and broader societal benefits.
Dr. Diwan
Research focus
My research delves into exploring the morphological and molecular changes in the cerebrovasculature following aneurysmal subarachnoid hemorrhage (aSAH). I am fervently driven by the prospect of identifying innovative therapeutic approaches aimed at averting or mitigating the consequences of Early Brain Injury (EBI) and Delayed Cerebral Ischemia (DCI) – the foremost preventable determinants of unfavorable outcomes in aSAH patients. My ultimate goal is to translate our promising preclinical therapeutic targets into tangible advancements for patients afflicted by a ruptured brain aneurysm, thereby leading to a paradigm shift in personalized medicine for prognostication and cerebroprotection in SAH.
View my publications in Google Scholar
Education
PhD, Genome Profiling
Department of Functional Materials Science
Saitama University
Saitama, Japan
2012 – 2015
MSc, Microbiology
Department of Biosciences
Mody University of Science and Technology
Rajasthan, India
2008 – 2010
BSc, Biotechnology
Chaudhary Charan Singh University
Meerut, India
2005 – 2008
Fellowship
Postdoctoral Fellow, Department of Biological and Biomedical Sciences
North Carolina Central University
Durham, NC
Honors and awards
- American Heart Association (AHA), Postdoctoral Fellowship, 2020
- Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Govt. Scholar, 2012
- DST-JSPS Scholar (India-Japan Cooperative Science Program, Joint Bilateral Research Project between University of Rajasthan, India and The University of Tokyo, Japan), 2011